ALMET

This brand name is authorized in Nigeria.

Active ingredients

The drug ALMET contains one active pharmaceutical ingredient (API):

1
UNII 56LH93261Y - METHYLDOPA
 

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
 
Read more about Alphamethyldopa

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-2761 Tablet ALMET TABLET TAB 250 mg 10 X 10PACK 35 RNW-PP-100957 ALMET TABLET METHYLOPA methyldopa B.P. 250mg B4-2761 Drugs CARDIOVASCULAR SYSTEM Nigerian Products 1010PACK Prescription Only Medicine (POM) 9/28/2019 REAGAN REMEDIES LIMITED, UMARU MUSA YARA'DUA DRIVE, OWERRI OWERRI IMO 8032223520 reganremedies@gmail.com REAGAN REMEDIES LIMITED, 24 UMARU MUSA YAR'ADUA DRIVE, OWERRI, IMO STATE, NIGERIA., Nigeria 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C02AB01 Methyldopa (levorotatory) C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-2761

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈